ConductScience.org, home

Paper28975475

Pharmacogenomics of Bucindolol in Atrial Fibrillation and Heart Failure.

Parikh KS and 1 other. Curr Heart Fail Rep, 2017. Cited by 2 papers, by iCite.

Cite this record

ConductScience Library. Pharmacogenomics of Bucindolol in Atrial Fibrillation and Heart Failure. Papers, record 28975475. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/28975475

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Pharmacogenomics of Bucindolol in Atrial Fibrillation and Heart Failure.
PubMed
Journal
Curr Heart Fail Rep
PubMed
Year
2017
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
2
iCite
Relative citation ratio, by iCite
0.07
iCite
Revised in PubMed
2018-11-13
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Parikh KSKishan S
2Piccini JPJonathan P

Source PubMed

Download CSV of authors

Topics9

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Atrial FibrillationMajor topic
Heart FailureMajor topic
PharmacogeneticsMajor topic
PropanolaminesMajor topic
Receptors, Adrenergic, beta-1Major topic
Stroke VolumeMajor topic
Adrenergic beta-Antagonists
Genotype
Humans

Source PubMed

Download CSV of topics

References36

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
124332148Genetic variation in the β1-adrenergic receptor is associated with the risk of atrial fibrillation after cardiac surgery.Am Heart J2014https://conductscience.org/library/papers/24332148PubMed
225125304Rhythm control in heart failure patients with atrial fibrillation: contemporary challenges including the role of ablation.J Am Coll Cardiol2014https://conductscience.org/library/papers/25125304PubMed
311386264A trial of the beta-blocker bucindolol in patients with advanced chronic heart failure.N Engl J Med2001https://conductscience.org/library/papers/11386264PubMed
411333992Race and the response to adrenergic blockade with carvedilol in patients with chronic heart failure.N Engl J Med2001https://conductscience.org/library/papers/11333992PubMed
524088125β1- and α2C-adrenergic receptor polymorphisms and the antiarrhythmic effect of bucindolol in heart failure with reduced ejection fraction.Pharmacogenomics2013https://conductscience.org/library/papers/24088125PubMed
624159564Prevention of atrial fibrillation by bucindolol is dependent on the beta₁389 Arg/Gly adrenergic receptor polymorphism.JACC Heart Fail2013https://conductscience.org/library/papers/24159564PubMed
727560277Rate control in atrial fibrillation.Lancet2016https://conductscience.org/library/papers/27560277PubMed
822617224Impact of the β1-adrenoceptor Arg389Gly polymorphism on heart-rate responses to bisoprolol and carvedilol in heart-failure patients.Clin Pharmacol Ther2012https://conductscience.org/library/papers/22617224PubMed
928089316Decreased Mortality With Beta-Blockers in Patients With Heart Failure and Coexisting Atrial Fibrillation: An AF-CHF Substudy.JACC Heart Fail2017https://conductscience.org/library/papers/28089316PubMed
1012374873Synergistic polymorphisms of beta1- and alpha2C-adrenergic receptors and the risk of congestive heart failure.N Engl J Med2002https://conductscience.org/library/papers/12374873PubMed
1125193873Efficacy of β blockers in patients with heart failure plus atrial fibrillation: an individual-patient data meta-analysis.Lancet2014https://conductscience.org/library/papers/25193873PubMed
1225443111Race, common genetic variation, and therapeutic response disparities in heart failure.JACC Heart Fail2014https://conductscience.org/library/papers/25443111PubMed
1322260944Association of β-blocker exposure with outcomes in heart failure differs between African American and white patients.Circ Heart Fail2012https://conductscience.org/library/papers/22260944PubMed
1415767288Prognostic relevance of atrial fibrillation in patients with chronic heart failure on long-term treatment with beta-blockers: results from COMET.Eur Heart J2005https://conductscience.org/library/papers/15767288PubMed
1519880803An alpha2C-adrenergic receptor polymorphism alters the norepinephrine-lowering effects and therapeutic response of the beta-blocker bucindolol in chronic heart failure.Circ Heart Fail2010https://conductscience.org/library/papers/19880803PubMed
1616697316
Atrial fibrillation and risk of clinical events in chronic heart failure with and without left ventricular systolic dysfunction: results from the Candesartan in Heart failure-Assessment of Reduction in Mortality and morbidity (CHARM) program.
J Am Coll Cardiol2006https://conductscience.org/library/papers/16697316PubMed
1725217435Potential applications of pharmacogenomics to heart failure therapies.Heart Fail Clin2014https://conductscience.org/library/papers/25217435PubMed
1825959096Bucindolol hydrochloride in atrial fibrillation and concomitant heart failure.Expert Rev Cardiovasc Ther2015https://conductscience.org/library/papers/25959096PubMed
191973638Effect of beta-adrenergic blockade on myocardial function and energetics in congestive heart failure. Improvements in hemodynamic, contractile, and diastolic performance with bucindolol.Circulation1990https://conductscience.org/library/papers/1973638PubMed
2010662755beta-adrenergic receptor blockade in chronic heart failure.Circulation2000https://conductscience.org/library/papers/10662755PubMed

See all 36 referencesDownload CSV of references

Cited by2

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 2 citations.

PMIDTitleJournalYearIn PapersSource
41372115The beta1-adrenergic receptor in the heart.Cell Death Discov2025https://conductscience.org/library/papers/41372115PubMed
35440173Premarket assessment of molecular alterations in drug targets: a case study of 2020 drug approvals.Pharmacogenomics2022https://conductscience.org/library/papers/35440173PubMed

Download CSV of cited by

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
ADRB1153PubTator's text mininghttps://conductscience.org/library/genes/153

Source NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/28975475

GET https://conductscience.org/api/papers/v1/28975475/references?page=2